Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease
Dawid Mehlich, Anna A. Marusiak
Topics & Concepts
Triple-negative breast cancerBreast cancerCancer researchTargeted therapyPI3K/AKT/mTOR pathwayReceptor tyrosine kinaseKinaseEstrogen receptorBiologyMedicineMAPK/ERK pathwayPopulationCancerBioinformaticsSignal transductionInternal medicineGeneticsEnvironmental healthHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyAdvanced Breast Cancer Therapies